UnknownNot Applicable

CPC in Adult Refractory Glaucoma

Egypt25 participantsStarted 2021-07-01

Plain-language summary

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with refractory glaucoma aging 18 years and older.
✓. Both sexes are included.
✓. Patients Capable of giving informed consent.
✓. Pseudophkic glaucoma.
✓. Aphakic glaucoma.
✓. Silicon oil induced glaucoma.
✓. Neovascular glaucoma.
✓. Inflammatory glaucoma.

Exclusion criteria

✕. Patients \<18 years of age.
✕. Patients controlled on regular antiglaucomatous therapy.
✕. Patients who cannot do regular follow up visits.
✕. Diffuse scleral staphyloma at the site of CPC.

What they're measuring

change in intraocular pressure

Timeframe: First day postoperative and 1 week

Trial details

NCT IDNCT04921098

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04

Contact for this trial

Mina A Besada, Resident

01280899267 mena011205@med.sohag.edu.eg

View on ClinicalTrials.gov More Refractory Glaucoma trials